NCT00392938View on ClinicalTrials.gov

Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

May 31, 2010

Conditions
Metastatic CancerProstate Cancer
Interventions
DRUG

antiandrogen therapy

DRUG

docetaxel

DIAGNOSTIC_TEST

C-11 acetate PET scan

DIAGNOSTIC_TEST

F-18 FDG PET scan

DIAGNOSTIC_TEST

Tc-99m bone scan

DIAGNOSTIC_TEST

CT scan of the chest, abdomen and pelvis

Trial Locations (2)

98195

University of Washington School of Medicine, Seattle

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT00392938 - Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone | Biotech Hunter | Biotech Hunter